IMPlementation of Continuous Glucose Monitoring in Children With Type 2 Diabetes
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Johns Hopkins University
- Enrollment
- 41
- Locations
- 2
- Primary Endpoint
- Percentage of Time in Range Glucose Control
Study Overview
Brief Summary
The purpose of this prospective study is to determine if trial use of a Dexcom G6 CGM system for a 10 day wear period in pediatric Type 2 diabetes patients improves short term time in range glucose control and 3-6 month glycemic control.
Detailed Description
The purpose of this prospective study is to determine if trial use of a Dexcom G6 CGM system for 10 days has an impact on short and long term glycemic control and behavior in youth onset Type 2 diabetes.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Supportive Care
- Masking
- None
Eligibility Criteria
- Ages
- 5 Years to 21 Years (Child, Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Type 2 diabetes, diabetes duration >3 months
Exclusion Criteria
- •Prior use of CGM
Outcomes
Primary Outcomes
Percentage of Time in Range Glucose Control
Time Frame: 5 days, 10 days
The percentage of total time that the patient uses the continuous glucose monitor (CGM) where the blood glucose falls between 70 and 180 mg/dL
Hemoglobin A1c
Time Frame: Baseline, 3 - 6 months
HbA1c at baseline and 3-6 month follow-up.
More Frequent Glycemic Control Monitoring
Time Frame: 10 days
Response to "Do you look at or check your blood sugar more often than before?"
More Frequent Insulin Administration
Time Frame: 10 days from CGM placement
Response to "Did you take your insulin more often than before?"
Secondary Outcomes
No secondary outcomes reported